Galectin Therapeutics Inc.GALTNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank14
Studio
Year-over-Year Change

Debt-to-equity ratio

Percentile
P14
Within normal range
vs 5Y Ago
-1205.1x
Contraction
Streak
2 yr
Consecutive growthCompressed
PeriodValueYoY Change
2024-1.03+13.5%
2023-1.19+3.7%
2022-1.24-111.1%
202111.11+610610.1%
20200.00+112.6%
20190.00-
20180.00-
20170.00-
20160.00-
20150.00-